A dynamic transmission model for assessing the impact of pneumococcal vaccination

Data Availability

Incidence data for invasive pneumococcal disease (IPD) in the US used for model calibration were generated by Merck & Co., Inc., Rahway, NJ, USA using serotype distribution data from Active Bacterial Core surveillance (ABCs), Centers for Disease Control and Prevention (CDC), and the annual IPD incidence from the annual CDC surveillance reports. All other data are publicly available, without restriction.